For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges are well known, such as loss of muscle ...

Share on Pinterest Recent research has found that despite the benefits, people using GLP-1s may be less likely to exercise. Image Credit: Fiordaliso/Getty Images A recent study found that people ...

Recent research has found that despite the benefits, people using GLP-1s may be less likely to exercise. Image Credit: Fiordaliso/Getty Images A recent study found that people who begin using a GLP-1 ...

On the off chance you are just joining the party, you might want to visit the earlier installments of this mega-mini-series. In a crunchy nutshell, in Part 1, we introduced unsigned and signed ...

Having gone from diabetes treatment to weight-loss miracle, GLP-1s are already blockbuster drugs. Now a new study in The Lancet shows that GLP-1s help with another common lifestyle disease: ...

Critics of artificial intelligence caution that, as a relatively new technology, its long-term effects on the human brain are still unknown. But a new study shows that AI could be dangerous even in ...

It seems like everyone is focused on improving their longevity and health span right now, doing whatever they can to prevent age-related diseases, extend the number of years they spend in good health, ...

A new study from the University of St Andrews suggests weight-loss drugs like Ozempic taken around pregnancy do not raise the risk of major birth defects. Published in the American Journal of ...

A GLP-1 medication helped people with obesity who were undergoing treatment for alcohol-use disorder drink less, according to new research. The study, which was published Friday in The Lancet, ...

A 26-week, randomized, double-blind trial in Copenhagen enrolled adults 18–70 years with AUD, BMI ≥30 kg/m², ≥6 heavy-drinking days, and AUDIT >15, assigning semaglutide vs placebo 1:1. Compared with ...